Treatment of Patients With Metastatic Urothelial Cancer “Unfit” for Cisplatin-Based Chemotherapy

Cisplatin-based combination chemotherapy is considered standard first-line treatment for patients with metastatic urothelial carcinoma. However, a large proportion of patients with metastatic urothelial carcinoma are considered "unfit" for cisplatin. The purpose of this review is to define...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical oncology 2011-06, Vol.29 (17), p.2432-2438
Hauptverfasser:	GALSKY, Matthew D, HAHN, Noah M, BELLMUNT, Joaquim, ROSENBERG, Jonathan, SONPAVDE, Guru, HUTSON, Thomas, OH, William K, DREICER, Robert, VOGELZANG, Nicholas, STERNBERG, Cora N, BAJORIN, Dean F
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antineoplastic Agents - therapeutic use Biological and medical sciences Carboplatin - therapeutic use Cisplatin - therapeutic use Clinical Trials, Phase II as Topic Clinical Trials, Phase III as Topic Comorbidity Humans Kidney - physiopathology Medical sciences Neoplasm Metastasis Tumors Urologic Neoplasms - drug therapy Urologic Neoplasms - pathology Urologic Neoplasms - physiopathology Urothelium - pathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!